The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

The cuts risk making the world a more dangerous place. To assess the impact of these measures, The Economist spoke to more ...

The mRNA platform enabled scientists to begin work on a vaccine within days of the publication of COVID-19’s genetic sequence. Clinical trials for an mRNA vaccine began weeks la ...

Researchers identified messenger RNA that is missing in pediatric high-grade glioma tumors but not in normal brain tissues.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

The deal gives Gilead ownership of a technology that can genetically modify immune cells inside the body, an approach could potentially widen access to CAR-T treatment.